Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Cancer or Tumor Profiling Market Size study, By Technology (Immunoassays, Hybridization, Next Generation Sequencing, Mass Spectrometry, other technologies), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal cancer, melanoma cancer, other cancer), By Applications (Clinical Application, Research Applications) and Regional Forecasts 2019-2026.

  • BIZ3218546
  • 200 Pages
  • July 2019
  • Healthcare
Download Sample    Get Discount   
 
Global Cancer or Tumor Profiling Market is valued approximately USD 5.87 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 10.74% over the forecast period 2019-2026. Growing focus for the development of personalized medicine, growing utility of biomarkers in tumor profiling and increasing R&D investments in cancer are some major trends that are responsible for the wide adoption of Cancer or Tumor Profiling globally. The market is majorly driven by increasing prevalence of cancer globally. The World Cancer Research Fund International (WCRFI) estimates that, nearly 2 million new cases of breast cancer are being detected every year and breast cancer is considered as the most common form of cancer in women globally. American Cancer Research Society (ACRS) anticipates by 2030, incident rate of breast cancer is expected to reach over 9.9million cases with over 5.5million annual deaths, primarily due to aging population. Incident rates of breast cancer are highest (46% in 2016) amongst women aged between 45-65 years across the globe. ACRS studies reveals that, with aging population prevalence rate of breast cancer amongst elderly women aged 55 years and above is bound to increase. Breast cancer represents 12% of all new cases of cancer amongst women in 2016, according to WCRFI. Europe leads the world with highest number (25% in 2016) of new breast cancer cases in the world followed by North America and Asia Pacific according to National Cancer Institute (NCI), USA. Belgium, Denmark, France, Netherlands, Bahamas and USA are countries with highest rates of breast cancer in the world according to WCRFI survey in 2016. Global economic burden due to breast cancer stood at $5.7 billion in 2016 according to ACRS. However, ACRS estimates, the economic burden on breast cancer is anticipated to reach over $8 billion by 2025. Increasing number of breast cancer cases would supplement global Cancer or Tumor profiling market for the forecasted period. However, lack of skilled professionals is a major factor that impede the growth of the Cancer or Tumor Profiling market over the forecast period.

On the basis of segmentation, the Cancer or Tumor Profiling market is segmented into technology, cancer type and application. The technology segment of global Cancer or Tumor Profiling market is classified into immunoassays, hybridization, next generation sequencing, mass spectrometry and other technologies of which immunoassays accounted for the largest market share owing to its cost-effectiveness, high sensitivity as well as technological advancements in this technology would propel the growth of the immunoassays. Based on the cancer type segment, the Cancer or Tumor profiling is bifurcated into breast cancer, lung cancer, prostate cancer, colorectal cancer, melanoma cancer and other cancer of which breast cancer segment holds the leading position owing to the increased awareness about breast cancer diagnosis, rising prevalence of breast cancer. The application segment includes clinical application and research application.

The regional analysis of Cancer or Tumor Profiling Market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America have occupied major share in the global Cancer or Tumor Profiling market. The major reasons for the dominance of North America are rising prevalence of cancer along with the high rate of adoption in this region. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific is witnessed owing to rising number of contract research organizations (CROs), growing demand for better healthcare services and increasing incidences of cancer.

The leading market players mainly include-

Illumina, Inc.

Qiagen N.V.

Neogenomics Laboratories, Inc.

HTG Molecular Diagnostics, Inc.

Genomic Health Inc.

Caris Life Sciences

Helomics Corporation

Nanostring Technologies, Inc.

Oxford Gene Technology

Ribomed Biotechnologies, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

Immunoassays

Hybridization

Next Generation Sequencing

Mass Spectrometry

Other Technologies

By Cancer Type:

Breast Cancer

Lung Cancer

Prostate Cancer

Colorectal Cancer

Melanoma Cancer

Others Cancer

By Application:

Clinical Application

Research Application

By Regions:

North America

U.S.

Canada

Europe

UK

Germany

ROE

Asia Pacific

China

India

Japan

ROAPEC

LAMEA

Brazil

Mexico

ROW

Middle East & Africa

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017

Base year – 2018

Forecast period – 2019 to 2026

Target Audience of the Global Cancer or Tumor Profiling Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Key Trends

1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)

1.3.1. Cancer or Tumor Profiling Market, by Technology, 2016-2026 (USD Billion)

1.3.2. Cancer or Tumor Profiling Market, by Cancer Type, 2016-2026 (USD Billion)

1.3.3. Cancer or Tumor Profiling Market, by Application, 2016-2026 (USD Billion)

1.3.4. Cancer or Tumor Profiling Market, by Region, 2016-2026 (USD Billion)

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Cancer or Tumor Profiling Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Industry Evolution

2.2.2. Scope of the Study

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Cancer or Tumor Profiling Market Dynamics

3.1. See Saw Analysis

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Cancer or Tumor Profiling Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Buyers

4.1.2. Bargaining Power of Suppliers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model

4.2. PEST Analysis

4.2.1. Political Scenario

4.2.2. Economic Scenario

4.2.3. Social Scenario

4.2.4. Technological Scenario

4.3. Key Buying Criteria (On Demand)

4.4. Regulatory Framework (On Demand)

4.5. Investment Vs Adoption Scenario (On Demand)

4.6. Analyst Recommendation & Conclusion

Chapter 5. Global Cancer/Tumour Profiling Market, By Technology

5.1. Market Snapshot

5.1. Market Performance - Potential Model

5.2. Global Cancer/Tumour Profiling Market, Sub Segment Analysis

5.2.1. Immunoassays

5.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)

5.2.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

5.2.2. Hybridization

5.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)

5.2.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

5.2.3. Next Generation Sequencing

5.2.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)

5.2.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

5.2.4. Mass Spectrometry

5.2.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)

5.2.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

5.2.5. Other Technologies

5.2.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)

5.2.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Global Cancer/Tumour Profiling Market, By Cancer Type

6.1. Market Snapshot

6.2. Market Performance - Potential Model

6.3. Global Cancer/Tumour Profiling Market, Sub Segment Analysis

6.3.1. Lung Cancer

6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)

6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

6.3.2. Breast Cancer

6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)

6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

6.3.3. Colorectal Cancer

6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)

6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

6.3.4. Prostate Cancer

6.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)

6.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

6.3.5. Melanoma Cancer

6.3.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)

6.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

6.3.6. Other Cancers

6.3.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)

6.3.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Global Cancer/Tumour Profiling Market, By Application

7.1. Market Snapshot

7.2. Market Performance - Potential Model

7.3. Global Cancer/Tumour Profiling Market, Sub Segment Analysis

7.3.1. Clinical Application

7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)

7.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

7.3.2. Research Application

7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)

7.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Global Cancer/Tumour Profiling Market, by Regional Analysis

8.1. Cancer/Tumour Profiling Market, Regional Market Snapshot (2016-2026)

8.2. North America Cancer/Tumour Profiling Market Snapshot

8.2.1. U.S.

8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.2.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.2.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.2.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.2.2. Canada

8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.2.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.2.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.2.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.3. Europe Cancer/Tumour Profiling Market Snapshot

8.3.1. U.K.

8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.3.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.3.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.3.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.3.2. Germany

8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.3.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.3.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.3.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.3.3. Rest of Europe

8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.3.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.3.3.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.3.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4. Asia Cancer/Tumour Profiling Market Snapshot

8.4.1. China

8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.4.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4.2. India

8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.4.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4.3. Japan

8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.4.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4.3.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4.4. Rest of Asia Pacific

8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.4.4.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4.4.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.4.4.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.5. Latin America Cancer/Tumour Profiling Market Snapshot

8.5.1. Brazil

8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.5.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.5.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.5.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.5.2. Mexico

8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.5.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.5.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.5.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.6. Rest of The World

8.6.1. South America

8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.6.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.6.1.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.6.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.6.2. Middle East and Africa

8.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)

8.6.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.6.2.3. Cancer Type breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.6.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 9. Competitive Intelligence

9.1. Company Market Share (Subject to Data Availability)

9.2. Top Market Strategies

9.3. Company Profiles

9.3.1. Illumina, Inc.

9.3.1.1. Overview

9.3.1.2. Financial (Subject to Data Availability)

9.3.1.3. Product Summary

9.3.1.4. Recent Developments

9.3.2. Qiagen N.V.

9.3.3. Neogenomics Laboratories, Inc.

9.3.4. HTG Molecular Diagnostics, Inc.

9.3.5. Genomic Health Inc.

9.3.6. Caris Life Sciences

9.3.7. Helomics Corporation

9.3.8. Nanostring Technologies, Inc.

9.3.9. Oxford Gene Technology

9.3.10. Ribomed Biotechnologies, Inc.

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.1.6. Research Assumption

List of Tables

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER OR TUMOR PROFILING MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER OR TUMOR PROFILING MARKET

TABLE 3. GLOBAL CANCER OR TUMOR PROFILING MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)

TABLE 7. GLOBAL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)

TABLE 8. GLOBAL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY CANCER TYPE 2016-2026 (USD BILLION)

TABLE 9. GLOBAL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)

TABLE 10. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, BY ELECTRIC VEHICLE, 2016-2026 (USD BILLION)

TABLE 11. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 12. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 13. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 14. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 15. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 16. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 17. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 18. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 19. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 20. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 21. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 22. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 23. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 24. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 25. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 26. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 27. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 28. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 29. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 30. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 31. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 32. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 33. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 34. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 35. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 36. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 37. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 38. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 39. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 40. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 41. GLOBAL CANCER OR TUMOR PROFILING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 42. GLOBAL CANCER OR TUMOR PROFILING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 43. U.S. CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 44. U.S. CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 45. U.S. CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 46. U.S. CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 47. U.S. CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 48. CANADA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 49. CANADA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 50. CANADA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 51. CANADA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 52. CANADA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 53. UK CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 54. UK CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 55. UK CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 56. UK CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 57. UK CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 58. GERMANY CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 59. GERMANY CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 60. GERMANY CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 61. GERMANY CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 62. GERMANY CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 63. ROE CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 64. ROE CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 65. ROE CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 66. ROE CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 67. ROE CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 68. CHINA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 69. CHINA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 70. CHINA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 71. CHINA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 72. CHINA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 73. INDIA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 74. INDIA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 75. INDIA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 76. INDIA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 77. INDIA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 78. JAPAN CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 79. JAPAN CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 80. JAPAN CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 81. JAPAN CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 82. JAPAN CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 83. ROAPAC CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 84. ROAPAC CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 85. ROAPAC CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 86. ROAPAC CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 87. ROAPAC CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 88. BRAZIL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 89. BRAZIL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 90. BRAZIL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 91. BRAZIL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 92. BRAZIL CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 93. MEXICO CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 94. MEXICO CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 95. MEXICO CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 96. MEXICO CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 97. MEXICO CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 98. ROLA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 99. ROLA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 100. ROLA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 101. ROLA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 102. ROLA CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 103. ROW CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 104. ROW CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 105. ROW CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 106. ROW CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 107. ROW CANCER OR TUMOR PROFILING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research